EUVIMEDEUVIMED entdecken
Crossref

COPD vs Type 2 Diabetes Mellitus

Fu-Shun Ko, James Cheng-Chung Wei, Fu-Shun Yen, Yu-Chieh Wang, Der-Yang Cho, Chih-Cheng Hsu, Chii-Min Hwu

CHEST · 2026-09

DOI: 10.1016/j.chest.2026.09.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CHEST, 2026-09. Verfasst von Fu-Shun Ko und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology and Metabolism, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Section of Endocrinology …. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Science and Technology Council, Ministry of Health and Welfare, Taipei Veterans General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: COPD and type 2 diabetes mellitus (T2DM) are both associated with bone fragility through distinct mechanisms. COPD is characterized by accelerated bone resorption, whereas T2DM is associated with impaired bone quality despite preserved bone mineral density. RESEARCH QUESTION: Does COPD confer greater skeletal hazards than T2DM, and does concomitant COPD and T2DM further increase the risks of osteoporosis and fractures? STUDY DESIGN AND METHODS: We conducted a nationwide retrospective cohort study using Taiwan's National Health Insurance Research Database. Propensity score matching was applied to construct 3 comparison cohorts of patients with T2DM, COPD, and concomitant COPD and T2DM. Adjusted hazard ratios (aHRs) for incident osteoporosis, major osteoporotic fractures, and site-specific fractures were estimated using multivariable Cox proportional hazards models after adjustment for demographic characteristics, comorbidities, and medication use. RESULTS: Compared with T2DM, COPD was associated with a significantly higher hazard of osteoporosis (aHR, 1.51; 95% CI, 1.35-1.69). Patients with concomitant COPD and T2DM also had higher hazards of osteoporosis (aHR, 1.39; 95% CI, 1.23-1.57), major osteoporotic fractures (aHR, 1.19; 95% CI, 1.08-1.32), spine fractures (aHR, 1.35; 95% CI, 1.16-1.58), and radioulnar fractures (aHR, 1.21; 95% CI, 1.02-1.43) than patients with T2DM alone. In contrast, osteoporosis and fracture risks were comparable between patients with concomitant COPD and T2DM and those with COPD alone. Subgroup analyses identified significant effect modification by sex, with the association between COPD and osteoporosis being stronger in male patients than in female patients. INTERPRETATION: Our results show that COPD is significantly more toxic to the skeleton than T2DM, and their coexistence amplifies fracture susceptibility compared with T2DM alone. Importantly, male patients with COPD represent a distinctly vulnerable population, exhibiting a pronounced susceptibility to disease-induced bone loss. Clinicians must prioritize early and targeted osteoporosis screening for patients with COPD, especially men.

Schlagwörter

Stichwörter der Autor:innen

COPDbone fragilitymajor osteoporotic fracturesosteoporosistype 2 diabetes mellitus

Autor:innen und Institutionen

  • Section of Endocrinology and Metabolism, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Section of Endocrinology and Metabolism, Department of Internal Medicine, Taipei City Hospital…
  • Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan; Institute of Medicine, C…
  • Dr Yen's Clinic, Taoyuan, Taiwan.
  • College of Medicine, China Medical University, Taichung, Taiwan; Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.
  • Translational Cell Therapy Center, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan; Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan; Graduate Institute…
  • Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan; Department of Health Services Administration, China Medical University, Taichung, Taiwan; Department of Family Medicine, Min-…

Förderung

  • National Science and Technology Council
  • Ministry of Health and Welfare
  • Taipei Veterans General Hospital
  • China Medical University Hospital Health System

Zitieren

APA

Ko, F. S., Wei, J. C., Yen, F. S., Wang, Y. C., Cho, D. Y., Hsu, C. C., & Hwu, C. M. (2026). COPD vs Type 2 Diabetes Mellitus. CHEST. https://doi.org/10.1016/j.chest.2026.09.018

Vancouver

Ko FS, Wei JC, Yen FS, Wang YC, Cho DY, Hsu CC, et al. COPD vs Type 2 Diabetes Mellitus. CHEST. 2026. doi:10.1016/j.chest.2026.09.018

BibTeX
@article{Ko2026,
  author = {Ko, Fu-Shun and Wei, James Cheng-Chung and Yen, Fu-Shun and Wang, Yu-Chieh and Cho, Der-Yang and Hsu, Chih-Cheng and Hwu, Chii-Min},
  title = {COPD vs Type 2 Diabetes Mellitus},
  journal = {CHEST},
  year = {2026},
  doi = {10.1016/j.chest.2026.09.018}
}
Kostenlos starten →